AAAAAA

   
Results: 1-8 |
Results: 8
CANCER-TREATMENT BY TARGETED DRUG-DELIVERY TO TUMOR VASCULATURE IN A MOUSE MODEL
Authors: ARAP W PASQUALINI R RUOSLAHTI E
Citation: W. Arap et al., CANCER-TREATMENT BY TARGETED DRUG-DELIVERY TO TUMOR VASCULATURE IN A MOUSE MODEL, Science, 279(5349), 1998, pp. 377-380
MOLECULAR HETEROGENEITY OF THE VASCULAR ENDOTHELIUM REVEALED BY IN-VIVO PHAGE DISPLAY
Authors: RAJOTTE D ARAP W HAGEDORN M KOIVUNEN E PASQUALINI R RUOSLAHTI E
Citation: D. Rajotte et al., MOLECULAR HETEROGENEITY OF THE VASCULAR ENDOTHELIUM REVEALED BY IN-VIVO PHAGE DISPLAY, The Journal of clinical investigation, 102(2), 1998, pp. 430-437
FUNCTIONAL-ANALYSIS OF WILD-TYPE AND MALIGNANT GLIOMA DERIVED CDKN2A-BETA ALLELES - EVIDENCE FOR AN RB-INDEPENDENT GROWTH SUPPRESSIVE PATHWAY
Authors: ARAP W KNUDSEN E SEWELL DA SIDRANSKY D WANG JYJ HUANG HJS CAVENEE WK
Citation: W. Arap et al., FUNCTIONAL-ANALYSIS OF WILD-TYPE AND MALIGNANT GLIOMA DERIVED CDKN2A-BETA ALLELES - EVIDENCE FOR AN RB-INDEPENDENT GROWTH SUPPRESSIVE PATHWAY, Oncogene, 15(17), 1997, pp. 2013-2020
POINT MUTATIONS CAN INACTIVATE IN-VITRO AND IN-VIVO ACTIVITIES OF P16(INK4A) CDKN2A IN HUMAN GLIOMA/
Authors: ARAP W KNUDSEN ES WANG JYJ CAVENEE WK HUANG HJS
Citation: W. Arap et al., POINT MUTATIONS CAN INACTIVATE IN-VITRO AND IN-VIVO ACTIVITIES OF P16(INK4A) CDKN2A IN HUMAN GLIOMA/, Oncogene, 14(5), 1997, pp. 603-609
CYCLIN-DEPENDENT KINASE-6 (CDK6) AMPLIFICATION IN HUMAN GLIOMAS IDENTIFIED USING 2-DIMENSIONAL SEPARATION OF GENOMIC DNA
Authors: COSTELLO JF PLASS C ARAP W CHAPMAN VM HELD WA BERGER MS HUANG HJS CAVENEE WK
Citation: Jf. Costello et al., CYCLIN-DEPENDENT KINASE-6 (CDK6) AMPLIFICATION IN HUMAN GLIOMAS IDENTIFIED USING 2-DIMENSIONAL SEPARATION OF GENOMIC DNA, Cancer research, 57(7), 1997, pp. 1250-1254
SUPPRESSION OF GLIOBLASTOMA ANGIOGENICITY AND TUMORIGENICITY BY INHIBITION OF ENDOGENOUS EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR
Authors: CHENG SY HUANG HJS NAGANE M JI XD WANG DG SHIH CCY ARAP W HUANG CM CAVENEE WK
Citation: Sy. Cheng et al., SUPPRESSION OF GLIOBLASTOMA ANGIOGENICITY AND TUMORIGENICITY BY INHIBITION OF ENDOGENOUS EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 93(16), 1996, pp. 8502-8507
LOSS OF P16(INK4) EXPRESSION IS FREQUENT IN HIGH-GRADE GLIOMAS
Authors: NISHIKAWA R FURNARI FB LIN H ARAP W BERGER MS CAVENEE WK HUANG HJS
Citation: R. Nishikawa et al., LOSS OF P16(INK4) EXPRESSION IS FREQUENT IN HIGH-GRADE GLIOMAS, Cancer research, 55(9), 1995, pp. 1941-1945
REPLACEMENT OF THE P16 CDKN2 GENE SUPPRESSES HUMAN GLIOMA CELL-GROWTH/
Authors: ARAP W NISHIKAWA R FURNARI FB CAVENEE WK HUANG HJS
Citation: W. Arap et al., REPLACEMENT OF THE P16 CDKN2 GENE SUPPRESSES HUMAN GLIOMA CELL-GROWTH/, Cancer research, 55(6), 1995, pp. 1351-1354
Risultati: 1-8 |